Cannabics Pharmaceuticals Inc. (CNBX) financial statements (2021 and earlier)

Company profile

Business Address #3 BETHESDA METRO CENTER
BETHESDA, MD 20814
State of Incorp. NV
Fiscal Year End August 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

11/30/2020
TTM
8/31/2020
8/31/2019
8/31/2018
8/31/2017
8/31/2016
8/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1847783,5221,3943,3681925
Cash and cash equivalents1847782661,3943,3681925
Short-term investments  3,256    
Prepaid expense16915228422715030
Advance royalties  500    
Total current assets:3539304,3071,6213,5172226
Noncurrent Assets
Property, plant and equipment8068631,00297412023
Long-term investments and receivables   590   
Long-term investments   590   
Advance royalties  3,863    
Other undisclosed noncurrent assets5404276,011    
Total noncurrent assets:1,3461,28910,8761,56412023
TOTAL ASSETS:1,6992,21915,1833,1853,6382429
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:219231215316387265114
Accrued liabilities      8
Other undisclosed accounts payable and accrued liabilities219231215316387265106
Derivative instruments and hedges, liabilities    661 
Due to related parties224224224224246224224
Other undisclosed current liabilities    0  
Total current liabilities:443455439539699491338
Noncurrent Liabilities
Total liabilities:443455439539699491338
Stockholders' equity
Stockholders' equity attributable to parent, including:1,2561,76514,7442,6462,939(467)(310)
Common stock14141312121110
Additional paid in capital15,40515,37215,3009,8406,4471,108959
Accumulated other comprehensive income (loss)(2,661)(2,774)2,810    
Accumulated deficit(14,286)(13,631)(6,164)(7,297)(3,520)(1,586)(1,279)
Other additional capital2,7842,7842,78490   
Other undisclosed stockholders' equity attributable to parent  (0)  0 
Total stockholders' equity:1,2561,76514,7442,6462,939(467)(310)
TOTAL LIABILITIES AND EQUITY:1,6992,21915,1833,1853,6382429

Income statement (P&L) ($ in thousands)

11/30/2020
TTM
8/31/2020
8/31/2019
8/31/2018
8/31/2017
8/31/2016
8/31/2015
Gross profit:5710106113 
Operating expenses(2,893)(3,051)(3,313)(3,818)(1,860)(393)(540)
Other undisclosed operating income (loss)00 (0)   
Operating loss:(2,887)(3,043)(3,304)(3,809)(1,854)(281)(540)
Nonoperating income (expense)(93)(4,424)4,579 (69)(28)(2)
Other nonoperating income (expense)(93)(4,424)4,437 (80)(27)(2)
Interest and debt expense (8) (1)(4)(7)(3)
Other undisclosed loss from continuing operations before equity method investments, income taxes(8)      
Income (loss) from continuing operations before equity method investments, income taxes:(2,988)(7,476)1,275(3,810)(1,927)(316)(544)
Other undisclosed income from continuing operations before income taxes      3
Income (loss) before gain (loss) on sale of properties:(2,988)(7,476)1,275(3,810)(1,927)(316)(541)
Other undisclosed net income (loss)  3,08833(7)  
Net income (loss):(2,988)(7,476)4,363(3,777)(1,934)(316)(541)
Other undisclosed net income (loss) attributable to parent88(3,230)  9 
Net income (loss) available to common stockholders, diluted:(2,980)(7,467)1,133(3,777)(1,934)(307)(541)

Comprehensive Income ($ in thousands)

11/30/2020
TTM
8/31/2020
8/31/2019
8/31/2018
8/31/2017
8/31/2016
8/31/2015
Net income (loss):(2,988)(7,476)4,363(3,777)(1,934)(316)(541)
Other comprehensive loss(2,068)      
Other undisclosed comprehensive income5,579      
Comprehensive income (loss):523(7,476)4,363(3,777)(1,934)(316)(541)
Other undisclosed comprehensive loss, net of tax, attributable to parent(8,233)(5,576)(420)    
Comprehensive income (loss), net of tax, attributable to parent:(7,711)(13,052)3,943(3,777)(1,934)(316)(541)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: